title: Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1.
abstract: OBJECTIVE
  To evaluate the efficacy of physiotherapy for urinary manifestations in patients with human T-lymphotropic virus 1-associated lower urinary tract dysfunction.
  
  
  METHODS
  Open clinical trial was conducted with 21 patients attending the physiotherapy clinic of the Hospital Universitário, Bahia, Brazil. Combinations of behavioral therapy, perineal exercises, and intravaginal or intra-anal electrical stimulation were used.
  
  
  RESULTS
  The mean age was 54 ± 12 years and 67% were female. After treatment, there was an improvement in symptoms of urinary urgency, frequency, incontinence, nocturia, and in the sensation of incomplete emptying (P < .001). There was also a reduction in the overactive bladder symptom score from 10 ± 4 to 6 ± 3 (P < .001) and an increase in the perineal muscle strength (P <.001). The urodynamic parameters improved, with reduction in the frequency of patients with detrusor hyperactivity from 57.9% to 42.1%, detrusor-sphincter dyssynergia from 31.6% to 5.3%, detrusor hypocontractility from 15.8% to 0%, and detrusor areflexia from 10.5% to 0%, with positive repercussions in the quality of life in all patients.
  
  
  CONCLUSIONS
  Physiotherapy was effective in cases of human T-lymphotropic virus 1-associated neurogenic bladder, reducing symptoms, increasing perineal muscle strength, and improving urodynamic parameters and quality of life.
authors.affiliation: Physiotherapy Department, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil; Postgraduate Program in Health Sciences, Federal University of Bahia School of Medicine, Salvador, Bahia, Brazil.
authors.forename: Rosana C P
authors.initials: RC
authors.lastname: Andrade
authors.affiliation: Immunology Service, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil; Postgraduate Program in Health Sciences, Federal University of Bahia School of Medicine, Salvador, Bahia, Brazil.
authors.forename: José A
authors.initials: JA
authors.lastname: Neto
authors.affiliation: Physiotherapy Department, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil.
authors.forename: Luciana
authors.initials: L
authors.lastname: Andrade
authors.affiliation: Physiotherapy Department, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil.
authors.forename: Tatiane S
authors.initials: TS
authors.lastname: Oliveira
authors.affiliation: Physiotherapy Department, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil.
authors.forename: Dislene N
authors.initials: DN
authors.lastname: Santos
authors.affiliation: Immunology Service, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil; Postgraduate Program in Health Sciences, Federal University of Bahia School of Medicine, Salvador, Bahia, Brazil.
authors.forename: Cassius J V
authors.initials: CJ
authors.lastname: Oliveira
authors.affiliation: Department of Gynecology, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil.
authors.forename: Márcio J
authors.initials: MJ
authors.lastname: Prado
authors.affiliation: Immunology Service, Complexo Hospitalar Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil; Gonçalo Moniz Research Center, Fiocruz, Salvador, Bahia, Brazil; National Institute of Science and Technology in Tropical Diseases (INCT-DT), MCT/CNPq, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil; Postgraduate Program in Health Sciences, Federal University of Bahia School of Medicine, Salvador, Bahia, Brazil. Electronic address: edgar@ufba.br.
authors.forename: Edgar M
authors.initials: EM
authors.lastname: Carvalho
mesh_terms: D005260:Female; D015490:HTLV-I Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D026741:Physical Therapy Modalities; D001750:Urinary Bladder, Neurogenic / Q000150:complications* / Q000628:therapy*